Literature DB >> 26829426

An Important Step Forward, but Still a Way to Go.

Wim A Wuyts1, Francesco Bonella2, Ulrich Costabel2, Vincent Cottin3, Michael Kreuter4, Venerino Poletti5, Paolo Spagnolo6,7.   

Abstract

Mesh：

Year:  2016        PMID： 26829426     DOI： 10.1164/rccm.201509-1763LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  2 in total

1.  Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.

Authors:  Michael Kreuter; Paolo Spagnolo; Wim Wuyts; Elisabetta Renzoni; Dirk Koschel; Francesco Bonella; Toby M Maher; Martin Kolb; Derek Weycker; Klaus-Uwe Kirchgässler; Ulrich Costabel
Journal:  Respiration       Date:  2017-04-12       Impact factor: 3.580

2.  Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Michael Kreuter; Svenja Ehlers-Tenenbaum; Karin Palmowski; Jacques Bruhwyler; Ute Oltmanns; Thomas Muley; Claus Peter Heussel; Arne Warth; Martin Kolb; Felix J F Herth
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.